Live Webinar

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Hosted by AJMC and Targeted Oncology

-- Days : -- HRS : -- MIN : -- SEC
Register Now →
Logo Image
|Articles|February 14, 2023

Supplements and Featured Publications

  • Suprachoroidal Triamcinolone Acetonide Injectable Suspension for Macular Edema Associated With Noninfectious Uveitis: An In-Depth Look at Efficacy and Safety

Participating Faculty: Suprachoroidal Triamcinolone Acetonide Injectable Suspension for Macular Edema Associated With Noninfectious Uveitis: An In-Depth Look at Efficacy and Safety

Faculty

Steven Yeh, MD

Professor of Ophthalmology & Director of the Retina and Uveitis Service

Truhlsen Eye Institute

University of Nebraska Medical Center

Omaha, NE


Thomas Ciulla, MD, MBA

Chief Medical Officer & Chief Development Officer

Clearside Biomedical

Alpharetta, GA


Volunteer Clinical Professor

Indiana University School of Medicine

Indianapolis, Indiana


Faculty Disclosures

These faculty have disclosed the following relevant commercial financial relationships or affiliations in the past 12 months.

Steven Yeh, MD

CONSULTANCIES OR PAID ADVISORY BOARDS

Bausch + Lomb, Adverum Biotechnologies, REGENXBIO


Thomas Ciulla, MD, MBA

STOCK OWNERSHIP

Clearside Biomedical


EMPLOYMENT

Clearside Biomedical

Articles in this issue

over 3 years ago

Suprachoroidal Triamcinolone Acetonide Injectable Suspension for Macular Edema Associated With Noninfectious Uveitis: An In-Depth Look at Efficacy and Safety